¦X¬ù§å¤k¤Í °Ñij­û³Q¤U¥O¹Dºp
³Q´¦©~¤k¤Í¬f¤å«o³ø¾P¥~¦a¶}¤ä

[2014.08.26] µoªí
°Ñij­û¥¬¥Ë­³¥£»P¤k¤Í©Ô´¶¦w¯S¡C

¡i©ú³ø±M°T¡j¦A¦³1¦W«O¦uÄÒ°Ñij­û³Q¨îµô¡M³o¦¸¬O°Ñij­û¼f§å¦X¬ùµ¹¦Û¤vªº¤kªB¤Í¡C°Ñij°|¾Þ¦u©e­û·|©P¤@¤U¥O¡M°Ñij­û¥¬¥Ë­³¥£(Pierre-Hugues Boisvenu)¥²¶·¦V°Ñij­û¦P¹±¹Dºp¡M¨Ã¥B¶i­×·í¥NºÞ²z½Òµ{¡C

°Ñij°|¾Þ¦u©e­û·|»¡¡M¥¬¥Ë­³¥£»P¤k¾­û¬ù·|¡M¨â¦¸©µÄò¦oªº¦X¬ù¡MIJ¥Ç§Q¯q½Ä¬ðªk³W¡M¥¼¦³ºÉ§Ö±Ä¨ú¸É±Ï±¹¬I¡MÀ³¦V°Ñij°|¦P¹±¹Dºp¡C

¥¬¥Ë­³¥£³Ì«á¦w±Æ¤k¤Í©Ô´¶¦w¯S(Isabelle Lapointe)¨ì§Oªº¿ì¤½«Ç¤u§@¡M¦oÂà¨ì°Ñij°|·s±^¦ì¡M¥LÁٸչϦw±Æ¦o¨â©P¯S§O°²´Á¡C

°Ñij°|¾Þ¦u±M­û¦b6¤ëµô©w¡M¥¬¥Ë­³¥£¹H¤Ï³W«h¡M¦ý¥L¥X©óµ½·N¡M«Øij¤£¤©¨îµô¡C°Ñij°|§Q¯q½Ä¬ð©e­û·|(Senate conflict of interest committee)ÀË°Q³oµô¨M¡M¨Ã¤U¥O±Ä¨ú¡u¸É§ï¦æ°Ê©M¨îµô¡v¡C

¸Ó©e­û·|«Øij¡R

*¥¬¥Ë­³¥£¡u¹H¤Ï¡m°Ñij­û§Q¯q½Ä¬ðªk¡n(Conflict of Interest Code for Senators)¡M¥¼¯à¨³³tªÈ¥¿¹ê»Ú»P©úÅ㪺§Q¯q½Ä¬ð°ÝÃD¡M¥¼¯àªý¤î¯u¥¿©M©úÅ㪺§Q¯q½Ä¬ð¡Mµ²ªG©Ò¦³°Ñij­û©M°Ñij°|ªº·G¥¿?¤½«H¤O¨ü·l¡v¡M¥²¶·¹Dºp¡C

*¥¬¥Ë­³¥£­n¤W°ö°V½Ò¡M¦Û¶O¾Ç²ß¦p¦óºûô«ê·íªº¹µ¥D©M¹µ­ûÃö«Y¡M¶i­×½Òµ{¨Æ¥ý¥Ñ©e­û·|§å­ã¡M¡u«OÃÒ¦n¦n²z¸Ñ¡M¦b¤½¦@¾÷ºcùØ¡M¹µ¥D¢w¢w¹µ­ûÃö«Yªº·í¥NºÞ²z°ò¥»²z©À¡v¡C

¶·¦Û¶O¾Ç²ßºÞ²z°ò¥»²z©À

°Ñij°|©e­û·|§@¥X¤W­z¨M©w¡M¥¬¥Ë­³¥£©P¤@¤£¸mµû¡C¥L¦b2010¦~¸u¥Î©Ô´¶¦w¯S°µ§U²z¡M¥L«á¨Ó»P¦oµo®i±B¥~±¡¡C2011¦~¡M«e°Ñij°|¾Þ¦u±M­û§i»|¥¬¥Ë­³¯S¡M»¡¥L»P©Ô´¶¦w¯SÄò¬ù¡M¦³§Q¯q½Ä¬ðªº¶ûºÃ¡M¦ý¥L¨S²z·|¡M¨â¦¸©µÄò¦oªº¦~«×¦X¬ù¡C

¶Ç´C©ÜÅS¡M¥¬¥Ë­³¥£¦b»í¥_§J¬Ù¥[¤B¿Õ(Gatineau)?¤k¤Íªº¦@ºÞ¬f¤å©~¦í31¤Ñ´Á¶¡¡M¦V°Ñij°|³ø¾P¥~¦a¶}¤ä¡M¦Ó¨º¼l¬f¤å¤j·H»P´ì¤ÓµØ¥u¦³¤@ªe¤§¹j¡C®ø®§©ÜÅS«á¡M¥¬¥Ë­³¥£¦b2013¦~²×¤î©Ô´¶¦w¯Sªº¦X¬ù¡C

¥¬¥Ë­³¥£Àò©e°Ñij­û®É¡M¥L¦b»í¬ÙªÙ¥¬¾|§J(Sherbrooke)©~¦í¡M¥i¥Ó³øÃB¥~¶}¾P¡C¥L¦b2012¦~»P©d¤l¤À©~«á¡M¤j³¡¤À®É¶¡«Ý¦b¥[¤B¿Õ¡M«o¦V°Ñij°|¥Ó³øÃB¥~¶}¾PÁ`ÃB2¸U¤¸¡C

§ó¦h¥[°ê·s»D
¡i©ú³ø±M°T¡jªüº¸§B¹F¬Ù«O¦uÄÒ»â³S­Ô¿ï¤H¿c¥d´µ¯ª§J(Thomas Lukaszuk¡A¹Ï)§V¤O¸ÑÄÀ¡M¬°¦ó¥L¦³¥¨ÃB¤½¶O¼Æ¾Ú©M¤â¾÷º©¹C¶O¶}¤ä¡M¥L»¡¨º... ¸Ô±¡
¡]´ì¤ÓµØ25¤é¥[·sªÀ¹q¡^¸ê²`»í¤H¬F¹Î°ê·|ij­û¨©©Ô¤Z´µ(Andre Bellavance¡A¹Ï)©P¤@»¡¡M¥L­n¸òÀH¦P¹±ªº¨B¥ï¡M°h¥X»í¤H¬FÄÒ¡M¦]¬°¥L... ¸Ô±¡
«¢¬Ä°Ñ»P·j¯Á±´ÀI²î´ÝÀe
¥[®³¤j¤½¶éºÞ²z§½¥Nªí®L¨½´µ(Ryan Harris)©P¤é¦b¬Ó®a®ü­xÄ¥¸¥¨Ê¤h¹y¸¹(HMCS Kingston)¤W¡M¦VÁ`²z«¢¬Ä²³ø¥L­Ì·j¯Á´IÄõ§J... ¸Ô±¡
¡i©ú³ø±M°T¡j¥[®³¤jºÊº»¤H­û¦b¹L¥h¨â¦~¶¡·j¥Xªº¬r«~?ªZ¾¹?¨p°s©M¹H¸T«~¤j¶q¼W¥[¡M¼W´T¶W¹L20%¡C ¥t¤@¤è­±¡M¥[®³¤jÃg±Ð¸pª§¨ú§ó¤jÅv¤O¡M¥´À»º»¤¤... ¸Ô±¡
4¹êÅç¯fµU¥´°w«á¦s¬¡ ¥[»s¥ìªi©Ô¬Ì­]ªì¨£®Ä
¡i©ú³ø±M°T¡j¥[®³¤j1®a¤p«¬»sÃĤ½¥qImmunovaccine Inc.¬P´Á¤@»¡¡M¥¦ªº¥ìªi©Ô¬Ì­]¦³µo®i¼ç¤O¡M4°¦µU¤l¸Õ¥Î³oºØ¬Ì­]«á¡M³£¯à¦s¬¡¡C... ¸Ô±¡

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2014 mingpaotor.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-9663 | Advertising Hotline Tel: (416) 673-8250